Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.5 USD | +6.92% | -3.45% | -20.42% |
10/05 | UBS Cuts Price Target on Arrowhead Pharmaceuticals to $71 From $75, Keeps Buy Rating | MT |
09/05 | Arrowhead Pharmaceuticals Swings to Loss in Fiscal Q2 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.42% | 2.85B | |
+6.69% | 111B | |
+11.01% | 106B | |
-12.73% | 22.24B | |
+0.15% | 21.25B | |
-4.50% | 18.97B | |
-37.85% | 18.52B | |
-10.77% | 16.81B | |
+38.44% | 12.54B | |
-25.47% | 8.09B |
- Stock Market
- Equities
- ARWR Stock
- News Arrowhead Pharmaceuticals, Inc.
- B. Riley Lowers Arrowhead Pharmaceuticals' Price Target to $59 From $65, Keeps Buy Rating